- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01838161
Improving Adolescent Vaccination in Appalachian Kentucky (INSPIRE)
Project INSPIRE: Improving Adolescent Vaccination in Appalachian Kentucky
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is not an interventional study in which subject will be given a investigator drug or device.
Part I of the INSPIRE intervention development will involve formative research interviews conducted with parents of adolescents. Interview questions will focus on reticence to vaccinate children. Participants will be a convenience sample recruited through contacts in local public health departments and community nurses recruited by flyer and the research study coordinators (UK study personnel). Interview sessions will be scheduled in advance and will take approximately 30 minutes.
Part II of the INSPIRE intervention development will be evaluated in a small clinic-based pilot study using the same pre-test/post-test intervention design as in the planned (Part III) trial. For the pilot testing, the investigators will pilot the vaccination vignettes in a health department (clinical) setting with eligible parents of adolescents. Eligible parents who are coming in for non-acute care appointments will be asked by a research nurse to enroll in a research study. The Investigator will then administer a pretest survey, expose participants (parents) to vignette condition using the iPad in the clinic, and a post-test survey measuring intention to receive appropriate adolescent vaccines for their child as well as perceived message effectiveness (for the vignette). At the conclusion of the study, the research personnel administering the study will refer the adolescent to the clinic staff who will offer adolescent vaccines at the conclusion of the study (and/or a cue to schedule an appointment for the adolescent to visit the clinic) and will be able to examine actual behavior by receiving informed consent (from parents and adolescent) for limited medical record review (to track adolescent receipt of vaccinations). The Investigator will perform this pilot study in one Kentucky River Area District health department clinic with 30 parents. This method has been used to pilot past interventions, and it is expected that this allow us to correct for any problems in either the design of the survey assessment or the intervention. If needed, the investigator can tweak the intervention and re-pilot using the same procedures before the randomized controlled trial. This pilot test will also provide the advantage of assuring us that the intervention procedure can translate to the clinic setting. The Investigator has experience with this translation from our 1-2-3 Pap video intervention which the investigators began in social settings (recruiting people at school and other community events) and moved into the clinic setting for dissemination.
Part III of the INSPIRE project will be evaluated in a site-based group randomized controlled trial design, with individual-level randomization also occurring within the intervention group. Community vaccination clinic and health education sites (staffed by local health department contracted personnel and project nurses) in the intervention and control conditions will be matched on percentage of free/reduced school lunch and relevant demographics. At the end of Year 1, one health site in each pair will be randomized to the enhanced video educational intervention (video vignettes + standard of care social marketing vaccine event) or a standard of care vaccination campaign (standard of care health department vaccine event) comparison group. Individuals in the intervention group randomized condition also will be randomized when recruitment occurs in non-school based locations. Assessments will be conducted using Automated iPad Audio Assisted Interviewing techniques at pretest, immediate post-test, and then medical record review at 1 month and 9 month follow-up points. The medical record review will entail examining the medical record for each adolescent vaccine received by the patient. Thus, the investigators will be able to examine behavior change (i.e., receipt of vaccination) for each of the different vaccine types and their single or multi-dose outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- University of Kentucky
-
Lexington, Kentucky, United States, 40475
- University of Kentucky
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parents/guardians with legal custody of a minor child
- Parents of children 11-18 years of age.
Exclusion Criteria:
- Parents under the age of 18
- Allergy to vaccinations
- Parent has made an informed decision not to vaccinate their child
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Part I
Interview questions will focus on reticence to vaccinate children.
|
Parental Interviews
|
Experimental: Part II
We will pilot the vaccination vignettes in a health department (clinical) setting with eligible parents of adolescents.
|
Parents will be exposed to an educational video intervention if they are enrolled in this intervention condition.
|
Experimental: Part III
|
•video educational
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Part I - Parent Interviews
Time Frame: 1 year
|
Interview questions will focus on reticence to vaccinate children.
Participants will be a convenience sample recruited through contacts in local public health departments, community nurses and the research study coordinators.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Part II - Intention to Vaccinate
Time Frame: 1 Year
|
The investigator will pilot the vaccination vignettes in a health department (clinical) setting with eligible parents of adolescents.
The Investigator will then expose parents to vignette condition using the iPad, administer a pretest survey, the video vignette, and a post-test survey measuring intention to receive appropriate adolescent vaccines for their child as well as perceived message effectiveness (for the vignette).
|
1 Year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Part III - Site-based group randomized controlled trial design - Vaccination outcomes
Time Frame: 1 year
|
Community vaccination clinic sites in the intervention and control conditions will be matched on percentage of free/reduced school lunch and relevant demographics.
Randomization will occur at the group and individual level.
One site in each pair will be randomized to the enhanced video educational intervention condition (within this group individuals will be randomized to video vignettes + standard of care vaccine education or the standard of care vaccine education) or a standard of care (standard of care vaccine education) comparison group.
The medical record review will allow us to examine behavior change (i.e., receipt of age-appropriate vaccinations) for each of the different vaccine types and their single or multi-dose outcomes.
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elisia Cohen, PhD, University of Kentucky
Publications and helpful links
General Publications
- Cohen, E. L. and K. J. Head (2014).
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 13-0026-P4S
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent Immunization
-
University of Colorado, DenverNational Cancer Institute (NCI); University of California, Los AngelesCompletedHPV Vaccine | Adolescent Health | Vaccine | Immunization | Reproductive Health | Preventive Health Services | Human Papiloma Virus Vaccine | Health RegistryUnited States
-
University of Alabama at BirminghamCompletedChildhood Immunization Completion | Childhood Immunization Dropout | Immunization Card | Center Based EducationPakistan
-
University of North Carolina, Chapel HillNorth Carolina Division of Public HealthCompletedImmunization | Adolescent Health ServicesUnited States
-
Duke UniversityUniversity of South Carolina; Fogarty International Center of the National... and other collaboratorsCompletedImmunizationTanzania
-
CAMC Health SystemCompleted
-
Auburn UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedImmunizationUnited States
-
Lifespan Healthcare Resource LimitedUnknown
-
Children's Hospital of PhiladelphiaThrasher Research FundCompleted
-
Florida State UniversityCompletedImmunizationUnited States
-
Geisinger ClinicCompletedImmunization ProgramsUnited States
Clinical Trials on Part I
-
Merck Sharp & Dohme LLCTerminated
-
Mineralys Therapeutics Inc.CompletedHypertension, RenalUnited States
-
Kyushu UniversityRecruitingGastric Cancer | Pancreatic CancerJapan
-
Organon and CoCompleted
-
Orion Corporation, Orion PharmaPRA Health SciencesTerminated
-
Chiesi Farmaceutici S.p.A.TerminatedNeonatal Respiratory Distress SyndromeItaly
-
Sunshine Lake Pharma Co., Ltd.Completed
-
Eli Lilly and CompanyCompleted
-
AstraZenecaParexelRecruiting
-
AstraZenecaCompleted